The record-high surge of initial public offerings (IPOs) in biopharma last year was especially good news for CEOs of many of those newly public companies.
SUBSCRIBE
Biohealth Innovation
Founding Member of
Biohealth Innovation
The record-high surge of initial public offerings (IPOs) in biopharma last year was especially good news for CEOs of many of those newly public companies.